Mia's Feed
Medical News & Research

Development of Biopsychosocial Criteria for Patients with Deafblindness

Development of Biopsychosocial Criteria for Patients with Deafblindness

Share this article

A new international initiative has established standardized biopsychosocial criteria for diagnosing and supporting individuals with deafblindness, enhancing global understanding and tailored services.

2 min read

A dedicated team has formulated a comprehensive set of biopsychosocial criteria to better understand and assist individuals experiencing deafblindness. This condition involves concurrent impairments in hearing and vision, creating unique challenges that surpass those of each impairment alone. Traditional compensatory methods often fall short, leading to significant communication barriers and accessibility issues.

The variability in how deafblindness is defined and recognized across different countries has historically limited access to appropriate services. While regions like Quebec provide specialized rehabilitation programs, other nations lack such support, leaving families to manage without tailored assistance. Led by Walter Wittich, a professor at the University of Montreal, the international initiative aims to standardize understanding through a set of diagnostic codes inspired by the World Health Organization's International Classification of Functioning, Disability and Health (ICF). The ICF offers a biopsychosocial framework that captures the full spectrum of a person's functioning, surpassing purely medical models.

This initiative resulted in the development of a refined core set of codes specifically for deafblindness, facilitating clearer communication among healthcare and social service professionals worldwide. The process involved four stages: research review, interviews with affected individuals, surveys with professionals, and clinical scenario analysis. Over four years, experts in multiple disciplines gathered and synthesized insights, culminating in three distinct core sets: a comprehensive list for policymaking, a medium set for clinical interprofessional communication, and a concise brief set for individual patient assessments.

Looking forward, Wittich plans to extend this work by creating tailored core sets for children and youth, as well as for individuals using sign language or older adults with deafblindness. He emphasizes the importance of including the voices of deafblind individuals themselves, who have historically been underrepresented in research and decision-making processes. With an estimated 165 million people globally living with some degree of combined hearing and vision loss, these developments mark a significant step toward more inclusive and effective care.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Use of Machine Learning in the Fight Against HIV

Researchers are advancing HIV treatment and vaccine development by employing machine learning and network analysis to better classify and understand the virus's evolving strains, paving the way for more effective therapies and cures.

FDA Approves Injectable Leqembi for Early Alzheimer's Disease Treatment

The FDA has approved Leqembi Iqlik, a new subcutaneous injectable for early Alzheimer's disease, offering a faster, more convenient treatment option for patients after initial IV therapy.

Innovative Approach Targeting the Epipharynx Offers New Hope for Long COVID Patients

New research identifies the epipharynx as a key site for residual SARS-CoV-2 RNA and immune activation in long COVID patients. Innovative treatment using epipharyngeal abrasive therapy shows promising results, paving the way for targeted therapies to address persistent symptoms.

Gummy Shark: A Safe and Sustainable Protein Alternative for Children with Fish Allergies

New research indicates that gummy shark may be a safe and sustainable dietary option for children with fish allergies, offering hope for better nutrition and allergy management.